Sinopharm Group Co. Ltd. (SHTDF)

USD 2.35

(-6.0%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 596.56 Billion 552.14 Billion 521.05 Billion 456.41 Billion 425.27 Billion 344.52 Billion
Cost of Revenue 548.05 Billion 504.71 Billion 477 Billion 416.09 Billion 387.74 Billion 313.29 Billion
Gross Profit 48.51 Billion 47.43 Billion 44.05 Billion 40.32 Billion 37.53 Billion 31.22 Billion
Operating Expenses 26.23 Billion 24.22 Billion 22.6 Billion 20.53 Billion 19.02 Billion 15.47 Billion
Selling, General and Administrative Expenses 26.14 Billion 24.9 Billion 23.19 Billion 21.19 Billion 19.46 Billion 15.88 Billion
Research and Development Expenses - - - - - -
Other Expenses 2.15 Billion 29.04 Million 56.4 Million 12.47 Million 467 Thousand 3.58 Million
Cost and Expenses 574.29 Billion 528.94 Billion 499.6 Billion 436.63 Billion 406.76 Billion 328.77 Billion
Operating Income 22.31 Billion 20.6 Billion 19.71 Billion 17.75 Billion 16.13 Billion 15.39 Billion
Interest Expense 2.95 Billion 3.52 Billion 3.75 Billion 3.42 Billion 3.44 Billion 4.15 Billion
Income Tax Expense 4.5 Billion 4.21 Billion 3.93 Billion 3.5 Billion 3.13 Billion 2.8 Billion
Earnings before Tax 19.51 Billion 18.56 Billion 17 Billion 15.59 Billion 13.75 Billion 12.2 Billion
Net Income 9.05 Billion 8.52 Billion 7.75 Billion 7.18 Billion 6.25 Billion 5.83 Billion
Earnings Per Share Basic 2.90 2.73 2.49 2.31 2.11 1.97
Earnings Per Share Diluted 2.90 2.73 2.49 2.31 2.10 1.96
Weighted Average Shares Outstanding 3.11 Billion 3.12 Billion 3.11 Billion 3.11 Billion 2.96 Billion 2.96 Billion
Weighted Average Shares Outstanding (Diluted) 3.11 Billion 3.12 Billion 3.11 Billion 3.11 Billion 2.97 Billion 2.97 Billion
Gross Margin 0.08 0.09 0.08 0.09 0.09 0.09
EBIT Margin 0.05 0.05 0.05 0.05 0.05 0.05
Profit Margin 0.02 0.02 0.01 0.02 0.01 0.02
EBITDA 26.89 Billion 26.24 Billion 24.68 Billion 22.61 Billion 20.31 Billion 16.67 Billion
Earnings Before Tax Margin 0.04 0.04 0.04 0.04 0.04 0.04

Income Statement Charts